Johnson & Johnson to buy Actelion for $30 billion, spin off R&D unit | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/26/johnson-johnson-to-buy-actelion-for-30-billion-spin-off-rd-unit/

ZURICH (Reuters) – U.S. healthcare giant Johnson & Johnson will acquire Swiss biotech company Actelion in a $30 billion all-cash deal that includes spinning off Actelion’s research and development pipeline, the companies said on Thursday. http://internationalnewslive.com/johnson-johnson-to-buy-actelion-for-30-billion-spin-off-rd-unit/